ISSN: 0929-1903
Journal Home
Journal Guideline
Cancer Gene Therapy Q1 Unclaimed
Cancer Gene Therapy is a journal indexed in SJR in Molecular Biology and Molecular Medicine with an H index of 99. It has a price of 3490 €. It has an SJR impact factor of 1,457 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,457.
Cancer Gene Therapy focuses its scope in these topics and keywords: tumor, cancer, rna, cells, virus, gene, induces, targeting, necrosis, breast, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -
3490 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
1,457
SJR Impact factor99
H Index165
Total Docs (Last Year)367
Total Docs (3 years)9395
Total Refs1780
Total Cites (3 years)354
Citable Docs (3 years)4.96
Cites/Doc (2 years)56.94
Ref/DocOther journals with similar parameters
Cell Research Q1
Molecular Cell Q1
Cell Host and Microbe Q1
Annual Review of Plant Biology Q1
Journal of Hematology and Oncology Q1
Compare this journals
Aims and Scope
Best articles by citations
Purging of human breast cancer cells from stem cell products with an adenovirus containing p53
View moreConditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity
View moreThe cellular oncogene EWS/activating transcription factor 1 is unable to activate adenovirus-borne promoters: Implications for cytotoxic prodrug therapy of malignant melanoma of soft parts
View moreDevelopment of a murine orthotopic model of leukemia: Evaluation of TP53 gene therapy efficacy
View moreInhibition of glioma cells in vitro and in vivo using a recombinant adenoviral vector containing an astrocyte-specific promoter
View moreExpression of the prodrug-activating enzyme DT-diaphorase via Ad5 delivery to human colon carcinoma cells in vitro
View moreInduction of Influenza Matrix Protein 1 and MelanA-specific T lymphocytes in vitro using mRNA-electroporated dendritic cells
View moreCloning and analysis of human UroplakinII promoter and its application for gene therapy in bladder cancer
View moreInterleukin-2 gene-transduced human leukemic cells induce major histocompatibility complex-restricted and -unrestricted anti-leukemic effectors in mixed lymphocyte-tumor cultures
View moreA nonviral carrier for targeted gene delivery to tumor cells
View moreLipofection of early passages of cell cultures derived from murine adenocarcinomas: In vitro and ex vivo testing of the thymidine kinase/ganciclovir system
View moreProtective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cells
View moreTransduction of murine colon carcinoma cells with interleukin-15 gene induces antitumor effects in immunocompetent and immunocompromised hosts
View moreEnhanced antitumor effect of EGF R-targeted p21WAF-1 and GM-CSF gene transfer in the established murine hepatoma by peritumoral injection
View moreCytosine deaminase suicide gene therapy for peritoneal carcinomatosis
View moreEnhanced antitumoral effect of adenovirus-mediated cytosine deaminase gene therapy by induction of antigen-presenting cells through stem cell factor/granulocyte-macrophage colony-stimulating factor gene transfer
View moreInduction of long-lasting cytokine effect by injection of IL-12 encoding plasmid DNA
View moreLong-term effects of plasmid-mediated growth hormone releasing hormone in dogs
View moreBone marrow-derived cells as carriers of recombinant immunomodulatory cytokine genes to lymphoid organs
View moreAdenoviral delivery of A-FOS, an AP-1 dominant negative, selectively inhibits drug resistance in two human cancer cell lines
View moreConstruction and characterization of DNA vaccines encoding the single-chain variable fragment of the anti-idiotype antibody 1A7 mimicking the tumor-associated antigen disialoganglioside GD2
View morehTERT-promoter-based tumor-specific expression of MCP-1 effectively sensitizes cervical cancer cells to a low dose of cisplatin
View moreIdentification of FGF receptor-binding peptides for cancer gene therapy
View moreGanciclovir-mediated cell killing and bystander effect is enhanced in cells with two copies of the herpes simplex virus thymidine kinase gene
View more
Comments